Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

NBIXNBIX
Showing 8 of 31 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in NEUROCRINE BIOSCIENCES INC

AQR CAPITAL MANAGEMENT LLC holds 3.8M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $643.5M as of 2026-Q2. The position was decreased (-22.7% shares). NBIX represents 0.2% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$643.5M

Current Shares

3.8M

Total Value Change

+$431.3M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.8M
-22.7%
$643.5M0.2%$168.54
0
2026-Q1
Increased
4.9M
+51.0%
$650.7M0.3%$131.14
52
2025-Q4
Increased
3.3M
+18.0%
$462.7M0.2%$140.95
44
2025-Q3
Increased
2.8M
+83.7%
$388.4M0.2%$140.27
58
2025-Q2
Increased
1.5M
+40.5%
$189.8M0.2%$125.42
48
2025-Q1
Decreased
1.1M
-43.4%
$118.9M0.1%$113.16
0
2024-Q4
Increased
1.9M
+2.9%
$258.9M0.3%$137.06
38
2024-Q3
Increased
1.8M
+50.7%
$212.2M0.3%$115.06
51

Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used